Bevacizumab as maintenance therapy in patients with metastatic colorectal cancer: A meta-analysis of individual patients’ data from 3 phase III studies
Salvatore, Lisa, Bria, Emilio, Sperduti, Isabella, Hinke, Axel, Hegewisch-Becker, Susanna, Aparicio, Thomas, Le Malicot, Karine, Boige, Valérie, Koeberle, Dieter, Baertschi, Daniela, Dietrich, Daniel, Tortora, Giampaolo, Arnold, Dirk
Published in Cancer treatment reviews (01.06.2021)
Published in Cancer treatment reviews (01.06.2021)
Get full text
Journal Article
Phase 2 Trial of Single-agent Everolimus in Chemotherapy-naive Patients with Castration-resistant Prostate Cancer (SAKK 08/08)
Templeton, Arnoud J, Dutoit, Valérie, Cathomas, Richard, Rothermundt, Christian, Bärtschi, Daniela, Dröge, Cornelia, Gautschi, Oliver, Borner, Markus, Fechter, Eva, Stenner, Frank, Winterhalder, Ralph, Müller, Beat, Schiess, Ralph, Wild, Peter J, Rüschoff, Jan H, Thalmann, George, Dietrich, Pierre-Yves, Aebersold, Ruedi, Klingbiel, Dirk, Gillessen, Silke
Published in European urology (01.07.2013)
Published in European urology (01.07.2013)
Get full text
Journal Article
Metformin in Chemotherapy-naive Castration-resistant Prostate Cancer: A Multicenter Phase 2 Trial (SAKK 08/09)
Rothermundt, Christian, Hayoz, Stefanie, Templeton, Arnoud J, Winterhalder, Ralph, Strebel, Räto T, Bärtschi, Daniela, Pollak, Michael, Lui, Lillianne, Endt, Kathrin, Schiess, Ralph, Rüschoff, Jan H, Cathomas, Richard, Gillessen, Silke
Published in European urology (01.09.2014)
Published in European urology (01.09.2014)
Get full text
Journal Article
Bevacizumab (BV) maintenance (M) after first-line chemotherapy (CT) plus BV for metastatic colorectal cancer (mCRC) patients (pts): A meta-analysis of individual pts data (IPD) from three phase III studies
Salvatore, Lisa, Bria, Emilio, Sperduti, Isabella, Hinke, Axel, Hegewisch-Becker, Susanna, Aparicio, Thomas, Le Malicot, Karine, Boige, Valerie, Koeberle, Dieter, Baertschi, Daniela, Dietrich, Daniel, Tortora, Giampaolo, Arnold, Dirk
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Population pharmacokinetic analyses of regorafenib and capecitabine in patients with locally advanced rectal cancer (SAKK 41/16 RECAP)
Schmulenson, Eduard, Bovet, Cédric, Theurillat, Regula, Decosterd, Laurent Arthur, Largiadèr, Carlo R., Prost, Jean‐Christophe, Csajka, Chantal, Bärtschi, Daniela, Guckenberger, Matthias, Moos, Roger, Bastian, Sara, Joerger, Markus, Jaehde, Ulrich
Published in British journal of clinical pharmacology (01.12.2022)
Published in British journal of clinical pharmacology (01.12.2022)
Get full text
Journal Article
Long‐term outcome of dasatinib first‐line treatment in gastrointestinal stromal tumor: A multicenter, 2‐stage phase 2 trial (Swiss Group for Clinical Cancer Research 56/07)
Montemurro, Michael, Cioffi, Angela, Dômont, Julien, Rutkowski, Piotr, Roth, Arnaud D., von Moos, Roger, Inauen, Roman, Toulmonde, Maud, Burkhard, Roger O., Knuesli, Claudio, Bauer, Sebastian, Cassier, Philippe, Schwarb, Heike, Le Cesne, Axel, Koeberle, Dieter, Bärtschi, Daniela, Dietrich, Daniel, Biaggi, Christine, Prior, John, Leyvraz, Serge
Published in Cancer (01.04.2018)
Published in Cancer (01.04.2018)
Get full text
Journal Article
Bevacizumab Continuation Versus Treatment Holidays After First-Line Chemotherapy With Bevacizumab in Patients With Metastatic Colorectal Cancer: A Health Economic Analysis of a Randomized Phase 3 Trial (SAKK 41/06)
Matter-Walstra, Klazien, Schwenkglenks, Matthias, Betticher, Daniel, von Moos, Roger, Dietrich, Daniel, Baertschi, Daniela, Koeberle, Dieter
Published in Clinical colorectal cancer (01.12.2016)
Published in Clinical colorectal cancer (01.12.2016)
Get full text
Journal Article
Eribulin as first-line treatment in older patients with advanced breast cancer: A multicenter phase II trial [SAKK 25/14]
Hasler-Strub, Ursula, Mueller, Andreas, Li, Qiyu, Thuerlimann, Beat, Ribi, Karin, Gerber, Stefan, von Moos, Roger, Fehr, Mathias, Rochlitz, Christoph, Zaman, Khalil, Aebi, Stefan, Hochstrasser, Andreas, Gick, Ute, Baertschi, Daniela, Greuter, Stefan, Schreiber, Alexander, Caspar, Clemens B., Trojan, Andreas, Condorelli, Rosaria, Ruhstaller, Thomas
Published in Journal of geriatric oncology (01.01.2023)
Published in Journal of geriatric oncology (01.01.2023)
Get full text
Journal Article
Cetuximab monotherapy and cetuximab plus capecitabine as first-line treatment in older patients with RAS- and BRAF wild-type metastatic colorectal cancer. Results of the multicenter phase II trial SAKK 41/10
Kienle, Dirk L., Dietrich, Daniel, Ribi, Karin, Wicki, Andreas, Quagliata, Luca, Winterhalder, Ralph C., Koeberle, Dieter, Horber, Daniel, Bastian, Sara, Kueng, Marc, Saletti, Piercarlo, Helbling, Daniel, Baertschi, Daniela, Lugli, Alessandro, Bernhard, Juerg, Andrieu, Christiane, von Moos, Roger
Published in Journal of geriatric oncology (01.03.2019)
Published in Journal of geriatric oncology (01.03.2019)
Get full text
Journal Article
Bevacizumab continuation versus treatment holidays after first-line chemotherapy with bevacizumab in patients with metastatic colorectal cancer: a health economic analysis of a randomised phase III trial (SAKK 41/06)
Matter-Walstra, Klazien, Schwenkglenks, Matthias, Betticher, Daniel, von Moos, Roger, Dietrich, Daniel, Baertschi, Daniela, Koeberle, Dieter
Published in Clinical colorectal cancer (2016)
Published in Clinical colorectal cancer (2016)
Get full text
Journal Article
Neoadjuvant chemoradiation (CRT) with or without panitumumab (Pan) in patients with K-ras unmutated, locally advanced rectal cancer (LARC): Final results of a randomized multicenter phase II trial (SAKK 41/07)
Helbling, Daniel, Bodoky, Gyorgy, Gautschi, Oliver, Hayoz, Stefanie, Bosman, Fred, Madlung, Axel, Gloor, Beat, Burkhard, Roger, Rauch, Daniel, Winterhalder, Ralph C., Saletti, Piercarlo, Widmer, Lukas, Borner, Markus M., Baertschi, Daniela, Yan, Pu, Koeberle, Dieter
Published in Journal of clinical oncology (20.01.2015)
Published in Journal of clinical oncology (20.01.2015)
Get full text
Journal Article
SAKK 24/09: Safety and tolerability of bevacizumab plus paclitaxel versus bevacizumab plus metronomic cyclophosphamide and capecitabine as first-line therapy in patients with HER2-negative advanced stage breast cancer—A multicenter, randomized phase III trial
Rochlitz, Christoph, von Moos, Roger, Bigler, Martin, Zaman, Khalil, Anchisi, Sandro, Küng, Marc, Baertschi, Daniela, Borner, Markus M., Rordorf, Tamara, Rauch, Daniel, Mueller, Andreas, Ruhstaller, Thomas, Vetter, Marcus, Bernhard, Juerg, Trojan, Andreas, Hasler-Strub, Ursula, Cathomas, Richard, Winterhalder, Ralph C.
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Neoadjuvant radiotherapy (RT) combined with capecitabine (Cape) and sorafenib (Sor) in patients (pts) with locally advanced, k-ras-mutated rectal cancer (LARC): A phase I/II trial SAKK 41/08
Von Moos, Roger, Koeberle, Dieter, Schacher, Sabina, Hayoz, Stefanie, Winterhalder, Ralph C., Roth, Arnaud, Bodoky, Gyorgy, Samaras, Panagiotis, Berger, Martin D, Rauch, Daniel, Saletti, Piercarlo, Plasswilm, Ludwig, Thum, Peter, Meier, Urs R., Yan, Pu, Izzo, Paola, Klingbiel, Dirk, Baertschi, Daniela, Zaugg, Kathrin
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Neoadjuvant radiotherapy (RT) combined with capecitabine (Cape) and sorafenib (Sor) in patients with locally advanced, K-ras-mutated rectal cancer (LARC): A phase I/II trial (SAKK 41/08)
Von Moos, Roger, Koeberle, Dieter, Winterhalder, Ralph C., Cathomas, Richard, Inauen, Roman Ignaz, Zwahlen, Daniel Rudolf, Roth, Arnaud, Helbling, Daniel, Gautschi, Oliver, Baertschi, Daniela, Kuehne, Reto, Von Briel, Thomas, Grzesiczek, Anja, Samaras, Panagiotis, Kollar, Attila, Klingbiel, Dirk, Zaugg, Kathrin
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
Bevacizumab continuation versus no continuation after first-line chemo-bevacizumab therapy in patients with metastatic colorectal cancer: A randomized phase III noninferiority trial (SAKK 41/06)
Koeberle, Dieter, Betticher, Daniel C., Von Moos, Roger, Dietrich, Daniel, Brauchli, Peter, Baertschi, Daniela, Matter-Walstra, Klazien, Winterhalder, Ralph C., Borner, Markus M., Anchisi, Sandro, Moosmann, Peter, Kollar, Attila, Saletti, Piercarlo, Roth, Arnaud, Frueh, Martin, Kueng, Marc, Popescu, Razvan A., Schacher, Sabina, Hess, Viviane, Herrmann, Richard
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
Bevacizumab Continuation Versus No Continuation After First-Line Chemo-Bevacizumab Therapy in Patients with Metastatic Colorectal Cancer: a Phase 3 Non-Inferiority Trial
Koeberle, Dieter, Betticher, Daniel, von Moos, Roger, Dietrich, Daniel, Brauchli, Peter, Baertschi, Daniela, Matter-Walstra, Klazien, Winterhalder, Ralph, Borner, Markus, Anchisi, Sandro, Moosmann, Peter, Kollar, Attila, Saletti, Piercarlo, Roth, Arnaud, Frueh, Martin, Kueng, Marc, Popescu, Razvan, Schacher, Sabina, Hess, Viviane, Herrmann, Richard
Published in Annals of oncology (01.06.2013)
Published in Annals of oncology (01.06.2013)
Get full text
Journal Article